FRANKLIN M BERGER
CIK 1273885 · Director · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.42M
Companies
13
Total Filings
118
Lifetime Open-Market Net
$11.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVIR | Director | 536,097 | $4.51 | $2.42M | -$238.2K | 13 | 2026-06-23 |
| Kezar Life Sciences, Inc. (KZR) Delisted | Director | 0 | $7.29 | $0 | $2.91M | 14 | 2026-05-11 |
| ESSA Pharma Inc. (EPIX) Delisted | Director | 784,404 | $0.20 | $157.8K | $1.36M | 8 | 2024-03-28 |
| RAIN | Director | 0 | $1.32 | $0 | $3.41M | 8 | 2024-01-26 |
| Atreca, Inc. (BCEL) Delisted | Director | 97,808 | $0.15 | $14.7K | $0 | 5 | 2023-06-15 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | 0 | $38.00 | $0 | $1.20M | 13 | 2021-04-19 |
| KINETA, INC./DE (PTI) Delisted | Director | 15,308 | — | — | $2.12M | 10 | 2020-07-01 |
| Forte Biosciences, Inc. (TOCA) Delisted | Director | 1,689 | — | — | $0 | 4 | 2019-10-04 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 4 | 2019-06-12 |
| Seagen Inc. (SGEN) Delisted | Director | 204,720 | $228.74 | $46.83M | $505.2K | 20 | 2014-02-25 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 500 | — | — | $1.9K | 2 | 2013-08-22 |
| EMIS | Director | — | $10.19 | — | $0 | 1 | 2009-05-19 |
| Diadexus, Inc. (AXC) Delisted | Director | — | — | — | $0 | 1 | 2008-06-11 |
Recent Filings · Page 11 of 12
118 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-06-23 | Seagen Inc. (SGEN) Delisted | Buy (P) | +7,000 | $140.3K | EDGAR |
| 2011-05-24 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-10-01 | Seagen Inc. (SGEN) Delisted | Exer (M) | +5,000 | $41.9K | EDGAR |
| 2010-08-25 | Seagen Inc. (SGEN) Delisted | Exer (M) | +13,000 | $98.1K | EDGAR |
| 2010-05-25 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-17 | Seagen Inc. (SGEN) Delisted | Mixed | +22,000 | $186.4K | EDGAR |
| 2010-03-31 | Seagen Inc. (SGEN) Delisted | Buy (P) | +11,500 | $138.5K | EDGAR |
| 2010-03-12 | Seagen Inc. (SGEN) Delisted | Buy (P) | +13,000 | $154.7K | EDGAR |
| 2009-12-29 | Seagen Inc. (SGEN) Delisted | Exer (M) | +10,000 | $51.1K | EDGAR |
| 2009-10-09 | Seagen Inc. (SGEN) Delisted | Exer (M) | +5,000 | $20.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.